- cafead   Sep 01, 2022 at 10:32: AM
via Study met primary safety and secondary immunogenicity endpoints
Boosted serum neutralizing antibodies in both naive and previously mRNA vaccinated subjects
article source
Boosted serum neutralizing antibodies in both naive and previously mRNA vaccinated subjects
article source